Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya

Clinical trial NCT07487077 · RECRUITING

Trial details

NCT number: NCT07487077
Sponsor: Albert B. Sabin Vaccine Institute
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cholera Vaccination

Start date: 2025-10-31
Primary completion: 2028-06-01
Enrollment: 1071

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.